Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al

被引：1
|
作者：
Yin, J. Kevin [1 ,2 ]
Harris, Rebecca C. [3 ,4 ]
Loiacono, Matthew M. [5 ]
Chit, Ayman [6 ]
Samson, Sandrine I. [6 ,7 ]
机构：
[1] Sanofi, Global Med Affairs, Singapore, Singapore
[2] Univ Sydney, Sydney, NSW, Australia
[3] Sanofi, Global Med Evidence Generat, Singapore, Singapore
[4] London Sch Hyg & Trop Med, London, England
[5] Sanofi, Global Med Evidence Generat, Swiftwater, PA USA
[6] Sanofi, Global Med Affairs, Lyon, France
[7] Univ Toronto, Toronto, ON, Canada
来源：
VACCINE | 2023年 / 41卷 / 27期
关键词：
D O I：
10.1016/j.vaccine.2022.12.034
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3948 / 3948
页数：1
相关论文
共 50 条
  • [1] Letter to editor regarding the systematic review and meta-analysis by Coleman et al. on the effectiveness of MF59-adjuvanted seasonal influenza vaccine in older adults
    Yin, J. Kevin
    Samson, Sandrine I.
    Nealon, Joshua
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 826 - 827
  • [2] The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda, A
    VACCINE, 2001, 19 (17-19) : 2673 - 2680
  • [3] Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato, S
    Granoff, D
    Minutello, M
    Lecchi, G
    Faccini, M
    Agnello, M
    Senatore, F
    Verweij, P
    Fritzell, B
    Podda, A
    VACCINE, 1999, 17 (23-24) : 3094 - 3101
  • [4] Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
    Villa, Marco
    Black, Steven
    Groth, Nicola
    Rothman, Kenneth J.
    Apolone, Giovanni
    Weiss, Noel S.
    Aquino, Ivana
    Boldori, Liana
    Caramaschi, Fausta
    Gattinoni, Antonio
    Malchiodi, Giancarlo
    Crucitti, Antonio
    Della Cioppa, Giovanni
    Scarpini, Elio
    Mavilio, Domenico
    Mannino, Salvatore
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1139 - 1145
  • [5] Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults
    Essink, Brandon
    Fierro, Carlos
    Rosen, Jeffrey
    Figueroa, Amparo L.
    Zhang, Bin
    Verhoeven, Carole
    Edelman, Jonathan
    Smolenov, Igor
    VACCINE, 2020, 38 (02) : 242 - 250
  • [6] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
    Domnich, Alexander
    Arata, Lucia
    Amicizia, Daniela
    Puig-Barbera, Joan
    Gasparini, Roberto
    Panatto, Donatella
    VACCINE, 2017, 35 (04) : 513 - 520
  • [7] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    Gasparini, R
    Pozzi, T
    Montomoli, E
    Fragapane, E
    Senatore, F
    Minutello, M
    Podda, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (02) : 135 - 140
  • [8] AS03-and MF59-Adjuvanted influenza vaccines in Children
    Wilkins, Amanda L.
    Kazmin, Dmitri
    Napolitani, Giorgio
    Clutterbuck, Elizabeth A.
    Pulendran, Bali
    Siegrist, Claire-Anne
    Pollard, Andrew J.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [9] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    R. Gasparini
    T. pozzi
    E. Montomoli
    E. Fragapane
    F. Senatore
    M. Minutello
    A. Podda
    European Journal of Epidemiology, 2001, 17 : 135 - 140
  • [10] Cross-protective potential of a MF59-adjuvanted quadrivalent influenza vaccine in older adults
    Isakova-Sivak, Irina
    Rudenko, Larisa
    LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 900 - 901
12345